297 related articles for article (PubMed ID: 32951606)
1. Integrated lipidomics and proteomics network analysis highlights lipid and immunity pathways associated with Alzheimer's disease.
Xu J; Bankov G; Kim M; Wretlind A; Lord J; Green R; Hodges A; Hye A; Aarsland D; Velayudhan L; Dobson RJB; Proitsi P; Legido-Quigley C;
Transl Neurodegener; 2020 Sep; 9(1):36. PubMed ID: 32951606
[TBL] [Abstract][Full Text] [Related]
2. Visualizing modules of coordinated structural brain atrophy during the course of conversion to Alzheimer's disease by applying methodology from gene co-expression analysis.
Sato K; Mano T; Matsuda H; Senda M; Ihara R; Suzuki K; Arai H; Ishii K; Ito K; Ikeuchi T; Kuwano R; Toda T; Iwatsubo T; Iwata A;
Neuroimage Clin; 2019; 24():101957. PubMed ID: 31400633
[TBL] [Abstract][Full Text] [Related]
3. APOE2 orchestrated differences in transcriptomic and lipidomic profiles of postmortem AD brain.
Lefterov I; Wolfe CM; Fitz NF; Nam KN; Letronne F; Biedrzycki RJ; Kofler J; Han X; Wang J; Schug J; Koldamova R
Alzheimers Res Ther; 2019 Dec; 11(1):113. PubMed ID: 31888770
[TBL] [Abstract][Full Text] [Related]
4. Pathway-based integration of multi-omics data reveals lipidomics alterations validated in an Alzheimer's disease mouse model and risk loci carriers.
Garcia-Segura ME; Durainayagam BR; Liggi S; Graça G; Jimenez B; Dehghan A; Tzoulaki I; Karaman I; Elliott P; Griffin JL
J Neurochem; 2023 Jan; 164(1):57-76. PubMed ID: 36326588
[TBL] [Abstract][Full Text] [Related]
5. Integrated proteomics and network analysis identifies protein hubs and network alterations in Alzheimer's disease.
Zhang Q; Ma C; Gearing M; Wang PG; Chin LS; Li L
Acta Neuropathol Commun; 2018 Mar; 6(1):19. PubMed ID: 29490708
[TBL] [Abstract][Full Text] [Related]
6. Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease.
Gómez-Pascual A; Naccache T; Xu J; Hooshmand K; Wretlind A; Gabrielli M; Lombardo MT; Shi L; Buckley NJ; Tijms BM; Vos SJB; Ten Kate M; Engelborghs S; Sleegers K; Frisoni GB; Wallin A; Lleó A; Popp J; Martinez-Lage P; Streffer J; Barkhof F; Zetterberg H; Visser PJ; Lovestone S; Bertram L; Nevado-Holgado AJ; Gualerzi A; Picciolini S; Proitsi P; Verderio C; Botía JA; Legido-Quigley C
Comput Biol Med; 2024 Jun; 176():108588. PubMed ID: 38761503
[TBL] [Abstract][Full Text] [Related]
7. Relationships Between Plasma Lipids Species, Gender, Risk Factors, and Alzheimer's Disease.
Lim WLF; Huynh K; Chatterjee P; Martins I; Jayawardana KS; Giles C; Mellett NA; Laws SM; Bush AI; Rowe CC; Villemagne VL; Ames D; Drew BG; Masters CL; Meikle PJ; Martins RN;
J Alzheimers Dis; 2020; 76(1):303-315. PubMed ID: 32474467
[TBL] [Abstract][Full Text] [Related]
8. Genetic perturbations of disease risk genes in mice capture transcriptomic signatures of late-onset Alzheimer's disease.
Pandey RS; Graham L; Uyar A; Preuss C; Howell GR; Carter GW
Mol Neurodegener; 2019 Dec; 14(1):50. PubMed ID: 31878951
[TBL] [Abstract][Full Text] [Related]
9. Using blood transcriptome analysis for Alzheimer's disease diagnosis and patient stratification.
Zhong H; Zhou X; Uhm H; Jiang Y; Cao H; Chen Y; Mak TTW; Lo RMN; Wong BWY; Cheng EYL; Mok KY; Chan ALT; Kwok TCY; Mok VCT; Ip FCF; Hardy J; Fu AKY; Ip NY
Alzheimers Dement; 2024 Apr; 20(4):2469-2484. PubMed ID: 38323937
[TBL] [Abstract][Full Text] [Related]
10. Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.
Wang M; Roussos P; McKenzie A; Zhou X; Kajiwara Y; Brennand KJ; De Luca GC; Crary JF; Casaccia P; Buxbaum JD; Ehrlich M; Gandy S; Goate A; Katsel P; Schadt E; Haroutunian V; Zhang B
Genome Med; 2016 Nov; 8(1):104. PubMed ID: 27799057
[TBL] [Abstract][Full Text] [Related]
11. A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's Disease.
Seyfried NT; Dammer EB; Swarup V; Nandakumar D; Duong DM; Yin L; Deng Q; Nguyen T; Hales CM; Wingo T; Glass J; Gearing M; Thambisetty M; Troncoso JC; Geschwind DH; Lah JJ; Levey AI
Cell Syst; 2017 Jan; 4(1):60-72.e4. PubMed ID: 27989508
[TBL] [Abstract][Full Text] [Related]
12. Deep proteomic network analysis of Alzheimer's disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease.
Johnson ECB; Dammer EB; Duong DM; Yin L; Thambisetty M; Troncoso JC; Lah JJ; Levey AI; Seyfried NT
Mol Neurodegener; 2018 Oct; 13(1):52. PubMed ID: 30286791
[TBL] [Abstract][Full Text] [Related]
13. Lipidomic Network of Mild Cognitive Impairment from the Mayo Clinic Study of Aging.
Wang X; Bui H; Vemuri P; Graff-Radford J; Jack CR; Petersen RC; Mielke MM
J Alzheimers Dis; 2021; 81(2):533-543. PubMed ID: 33814434
[TBL] [Abstract][Full Text] [Related]
14. The Differential Influence of Immune, Endocytotic, and Lipid Metabolism Genes on Amyloid Deposition and Neurodegeneration in Subjects at Risk of Alzheimer's Disease.
Femminella GD; Harold D; Scott J; Williams J; Edison P;
J Alzheimers Dis; 2021; 79(1):127-139. PubMed ID: 33216025
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid lipidomics for biomarkers of Alzheimer's disease.
Byeon SK; Madugundu AK; Jain AP; Bhat FA; Jung JH; Renuse S; Darrow J; Bakker A; Albert M; Moghekar A; Pandey A
Mol Omics; 2021 Jun; 17(3):454-463. PubMed ID: 34125126
[TBL] [Abstract][Full Text] [Related]
16. Hippocampus Proteomics and Brain Lipidomics Reveal Network Dysfunction and Lipid Molecular Abnormalities in APP/PS1 Mouse Model of Alzheimer's Disease.
Zhang X; Liu W; Cao Y; Tan W
J Proteome Res; 2020 Aug; 19(8):3427-3437. PubMed ID: 32510958
[TBL] [Abstract][Full Text] [Related]
17. Identification of Potential Therapeutic Targets of Alzheimer's Disease By Weighted Gene Co-Expression Network Analysis.
Zhang F; Zhong SR; Yang SM; Wei YT; Wang JJ; Huang JL; Wu DP; Zhong ZG
Chin Med Sci J; 2020 Dec; 35(4):330-341. PubMed ID: 33413749
[TBL] [Abstract][Full Text] [Related]
18. Total Cholesterol and APOE-Related Risk for Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative.
Dunk MM; Driscoll I;
J Alzheimers Dis; 2022; 85(4):1519-1528. PubMed ID: 34958023
[TBL] [Abstract][Full Text] [Related]
19. An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer's disease.
Clark C; Dayon L; Masoodi M; Bowman GL; Popp J
Alzheimers Res Ther; 2021 Apr; 13(1):71. PubMed ID: 33794997
[TBL] [Abstract][Full Text] [Related]
20. Association between structural brain features and gene expression by weighted gene co-expression network analysis in conversion from MCI to AD.
Wang X; Huang K; Yang F; Chen D; Cai S; Huang L
Behav Brain Res; 2021 Jul; 410():113330. PubMed ID: 33940051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
